Abstract:Alkali burn is one of the main causes of corneal injury. The inflammation and neovascularization caused by alkali burns aggravate corneal damage, resulting in loss of vision. The aim of the present study was to evaluate the efficacy of xanthatin in the treatment of alkali burn-induced inflammation and neovascularization. A CCK-8 assay was used to detect the effects of different concentrations of xanthatin on the proliferation of human umbilical vein endothelial cells (HUVECs). The effects of xanthatin on the migration of HUVECs and the ability of lumen formation were examined using a scratch test and lumen formation assay, respectively. A total of 60 Sprague-Dawley rats were randomly divided into two groups to establish a corneal alkali burn model, and were treated with PBS and xanthatin eye drops four times a day. A slit lamp microscope recorded changes of the cornea at 0, 4, 7, 10 and 14 days, and the inflammatory indices of the cornea and the neovascular area were evaluated. The expression levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in the cornea under different treatment conditions were detected using immunofluorescence and western blot analysis. In order to investigate the mechanism of xanthatin on the inhibition of inflammation and neovascularization, HUVECs were treated with xanthatin and PBS following VEGF treatment. The subcellular localization of signal transducer and activator of transcription 3 (STAT3) was detected using immunofluorescence. The expression levels of VEGF receptor 2 (VEGFR2), STAT3, phosphoinositide 3-kinase (PI3K) and Akt were detected using western blot analysis. The results revealed that xanthatin inhibited the proliferation of HUVECs in a concentration-dependent manner. The migration ability and lumen-forming ability of the HUVECs were also inhibited by xanthatin. Slit lamp microscopy showed that the inflammatory index and the area of neovascularization in the xanthatin-treated group were significantly reduced, compared with those in the PBS treatment group. The xanthatin treatment group exhibited a lower protein expression level of VEGF and increased protein expression level of PEDF, compared with the PBS treatment group. In the VEGF-treated HUVECs, xanthatin significantly decreased the expression levels of p-VEGFR2, phosphorylated (p-)STAT3, p-PI3K and p-Akt. In conclusion, the present study confirmed that xanthatin inhibited corneal neovascularization and inflammation in the alkali burn model, elucidating the underlying mechanisms involved in its protective effects. Therefore, xanthatin may be a novel drug for the treatment of corneal alkali burn.

A Moderate Dosage of Prostaglandin E2-mediated Annexin A1 Upregulation Promotes Alkali-Burned Corneal Repair

Acetylsalicylic Acid Promotes Corneal Epithelium Migration by Regulating Neutrophil Extracellular Traps in Alkali Burn

Neutrophil extracellular traps promote corneal neovascularization-induced by alkali burn

Emodin Suppresses Alkali Burn-Induced Corneal Inflammation and Neovascularization by the Vascular Endothelial Growth Factor Receptor 2 Signaling Pathway.

Targeting HMGB1-NFκb Axis and miR-21 by Glycyrrhizin: Role in Amelioration of Corneal Injury in a Mouse Model of Alkali Burn

Pretranscriptional regulation of Tgf-beta1 by PI polyamide prevents scarring and accelerates wound healing of the cornea after exposure to alkali.

Subconjunctival Injection of Regulatory T Cells Potentiates Corneal Healing Via Orchestrating Inflammation and Tissue Repair after Acute Alkali Burn.

Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome

Aloin alleviates corneal injury in alkali burn via inhibiting neutrophil extracellular traps and promoting Nrf2

Drp1-dependent mitochondrial fission mediates corneal injury induced by alkali burn

Epigenetic Landscape Analysis of the Long Non-Coding RNA and Messenger RNA in a Mouse Model of Corneal Alkali Burns

Therapeutic eﬀects of a novel venom abstract (ZK002) solution in an alkali-burned corneal wound-healing model

Expression of proinflammatory cytokine, chemokine and its receptor in mouse cornea after alkali injury

Involvement Of Nadph Oxidases In Alkali Burn-Induced Corneal Injury

Cyclo-peptide CHSDGIC on promoting healing of corneal alkali burn in rabbits

Development of an injectable oxidized dextran/gelatin hydrogel capable of promoting the healing of alkali burn-associated corneal wounds

An electrospun scaffold functionalized with a ROS-scavenging hydrogel stimulates ocular wound healing

Study about corneal alkali burn treating with IL-1ra gene in rats

Xanthatin Inhibits Corneal Neovascularization by Inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt Signaling Pathway.

Effect of amniotic membrane extract on the expressions of vascular endothelial growth factor and vascular cell adhesion molecule-1 after coneal alkali burn in rats

Upadacitinib Inhibits Corneal Inflammation and Neovascularization by Suppressing M1 Macrophage Infiltration in the Corneal Alkali Burn Model.